文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > constitutive activity and inverse agonists of G protein-coupled receptors a current perspective.full
侵权投诉

constitutive activity and inverse agonists of G protein-coupled receptors a current perspective.full

A transmembrane intracellurlar estroge receptor medites rapid cell signaling

0026-895X/03/6406-1271–1276$7.00MOLECULARPHARMACOLOGY

Copyright©2003TheAmericanSocietyforPharmacologyandExperimentalTherapeuticsMolPharmacol64:1271–1276,2003

Vol.64,No.62756/1109668PrintedinU.S.A.

MINIREVIEW

ConstitutiveActivityandInverseAgonistsofGProtein-CoupledReceptors:aCurrentPerspective

GRAEMEMILLIGAN

MolecularPharmacologyGroup,DivisionofBiochemistryandMolecularBiology,InstituteofBiomedicalandLifeSciences,UniversityofGlasgow,Glasgow,Scotland,UnitedKingdomReceivedJune20,2003;acceptedAugust29,2003

Thisarticleisavailableonlineatdoc.guandang.net

ABSTRACT

Overthelastdecade,theabilitytodetectagonist-independentsignaltransductionbyGprotein-coupledreceptorshasinturnresultedinthedetectionandstudyofligandsabletoblockthisactivity.Suchligandsaregenericallydescribedasinverseago-

nists.Considerableattentionhasrecentlybeendevotedtothepresenceandrolesofendogenousantagonist/inverseagonistsandtheconceptthatinverseagonistsmayhavespecificther-apeuticbenefitscomparedwithneutralantagonists.

Althoughnowappreciatedtorepresentasubstantialover-simplification(MilliganandIJzerman,2000;Strange,2002),thetwo-statemodelofGPCRfunction(Samamaetal.,1993)remainsanextremelyusefulconcept.Agonistligandsstabi-lizeorincreasethefractionoftheactivestateofaGPCRsuchthatitcaninteractwithandactivateaGprotein.Assuch,basicthermodynamicsdefinethattheremustbeafiniteprobabilitythatthisactivestatealsooccursintheabsenceoftheagonist.Equally,ifagonistsenrichsuchactivestates,thenitshouldbepossibletoidentifyligands(inverseago-nists)thatstabilizeorenrichtheinactivestate.Withhind-sight,itiseasytoarguethatcompounds(neutralantago-nists)thatbindtoGPCRswithoutalteringtheequilibriumbetweenactiveandinactivestatesofthereceptorarelikelytoberatherrare.However,earlycartoonsthatspecificallyillustratedthispoint(Milliganetal.,1995)werecontentiousbecausetheydidnotreflectpharmacologicalexperienceinwhich‘antagonists’werecommonreagents.However,withinsuchmodels,thescaleofligandefficacyrangedfrom1(fullagonist)to 1(fullinverseagonist)andneutralantagonistsweredefinedverypreciselyaspossessing0efficacy.Heter-ologousexpressionofmanyGPCRsresultedinthedetectionofligand-independentsignaltransductionthatincreasedinanessentiallylinearfashionwithincreasinglevelsofGPCRexpression(TiberiandCaron,1994).Aftercleardemonstra-ThisworkisbasedonapresentationtotheAmericanSocietyforPharma-cologyandExperimentalTherapeuticsmeetinginSanDiegoon12April2003.

tionthattheconstitutiveactivityoftheGPCRwasnotasso-ciatedwiththepresenceoflowconcentrationsofendogenousagonists,theabilityofmanytraditional‘antagonists’toblocktheconstitutiveactivityofexpressedGPCRsrapidlysawthesecompoundsreclassifiedasinverseagonists(Milliganetal.,1995).ThisprocesscontinuestothepresentwithmanystudiesstillreportingtheinverseagonistactivityofligandsatawiderangeofbothnativeandmutatedGPCRs(DaefflerandLandry,2000).Compoundswithclosetozeroefficacyarevitaltoolsinligandclassificationbecauseanycompoundwiththischaracteristicthatbindsinacompetitivemannerwillactasafunctionalantagonisttocompoundswithagonistorinverseagonistproperties.Theycanthusbeusedtoex-cludeapparentinverseagonismthatderivesfromcompeti-tionwithanendogenousligandratherthanviasuppressionofreceptorconstitutiveactivity.

GPCRsDisplayVaryingLevelsof

ConstitutiveActivity

AkeyquestionforthepotentialimportanceofinverseagonistsandwhethertheymayhaveinherentbenefitsastherapeuticagentsrelatestothelevelofconstitutiveactivityofindividualGPCRs.Manyclinicallyimportantmedicineshavebeendemonstratedtobehaveasinverseagonistswhentestedagainsteitherwild-typeormutatedGPCRs(Table1).Inmostcases,thesestudieshaveusedGPCRsexpressedrecombinantlyincelllines,butincertaincases,significant

ABBREVIATIONS:GPCR,Gprotein–coupledreceptor;RGS,regulatorofGproteinsignaling;MSH,melanocyte-stimulatinghormone;AGRP,agouti-relatedpeptide;mGluR,metabotropicglutamatereceptor;PDZ,postsynapticdensity95/disc-large/ZO-1.

1271

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email